MF
AMAG

Magnetar Financial’s AMAG Pharmaceuticals AMAG Stock Holding History

Magnetar Financial’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-36,351
Closed -$363K – 615
2019
Q2 		$363K Buy
36,351
+16,099
+79% +$174K 0.01% 335
2019
Q1 		$261K Sell
20,252
-8,253
-29% -$123K 0.01% 338
2018
Q4 		$433K Buy
+28,505
New +$543K 0.01% 163

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Magnetar Financial's AMAG Position: Q3 2019 in Review

Magnetar Financial sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 36,351 shares — an estimated $363K sold.

Magnetar Financial first reported a position in AMAG in Q4 2018 and held it in 3 quarters. The position peaked at $433K in Q4 2018. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • Magnetar Financial reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Magnetar Financial sold 36,351 AMAG Pharmaceuticals shares in Q3 2019, an estimated $363K.
  • Magnetar Financial first reported a position in AMAG Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Magnetar Financial's AMAG Pharmaceuticals position peaked at $433K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Magnetar Financial's 13F filing for Q3 2019, filed 14 Nov 2019.